`
`
`
`
`IN THE UNITE!) STATES PATENT
`
`
`
`
`
`GFFICE‘
`
`
`Patgnme;
`
`PatentNm
`
`
`
`
`Rfiexaminafign
`
`
`Emmi Na:
`
`Filed:
`
`
`
`Hated:
`
`
`
`
`
`
`
`Ya:ng at al.
`
`USS. 35,897,081}
`
`
`9&5{3262 s,1 76
`
`
`
`
`
`September- 16? 2612
`
`
`
`
`Examiner:
`
`
`(31-9111: Art Unit:
`
`
`Confirmatian
`
`Na,
`
`
`
`
`H&B.Bgekett
`
`
`
`
`
`
`
`Diamafid; Avian
`
`
`
`641. 8'
`
`3991
`
`
`1199423
`
`RCEXCQNXREX
`
`
`
`March 13,, 2813
`
`
`
`
`M&E Dmket:
`
`
`
`11W44~80023
`
`
`
`
`
`
`
`
`
`Mai} ‘Smp Int-er Farms: Raexam
`
`
`
`Central Reexaminatign Unit
`
`
`
`.Cenunissienfir fax-Patents.
`
`
`
`
`15.3,. Patem and Tiademarkflffice
`
`
`
`PD, Bax '1 4.3.0
`
`
`Aiexandria; VA 22313-1452}
`
`
`
`
`
`
`
`
`
`Certficate afEFS Web Tratzsrxzissian
`
`
`
`
`
`
`
`
`i’keréby 363??ny {km firis aarrespmdeme is being.
`
`
`
`
`
`
`
`imnsmified via the {£81. Pawn! and fi‘adeimxk
`
`
`
`
`
`Ojj‘ifie giacz‘z'flnicjfiimg3325:6321 (Efi’Si Wait?) 1:9 the
`
`
`USP??? an
`
`
`
`March 13. 2mg.
`
`
`
`
`Michaei ‘1; wakcms: . a KMicfzaei I
`
`Chakansl: 42‘"
`
`
`
`
`
`
`
`
`
`
`BECLARAT’IQN OF B. ARLEE ROGUE,
`
`
`
`
`
`
`
`UNDER 37
`
`
`
`
`§ 1.132
`
`
`
`Madama:
`
`
`
`
`
`
`
`
`
`
`
`I, 13; Arm- Vli’sraguzej 1311.3, ck; hereby make: the; feltuwing declaration:
`
`
`
` (cid:9)
`
`
`TecimitaalBaak
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`fiaid 0f pharmacmfieat dwelopmeng and particuiarliy oral {Engage
`‘. mam worked
`
`
`
`
`
`
`
`
`
`
`
`
`devempmenti far 22' years. I am ainployed by: MomSoi
`LLC. (“Patmtee" andfm‘
`
`
`
`
`
`
`
`
`
`
`
`
`
`“MemS-ol")3 me. assignea afissued patani
`"33897-301
`(“mg ‘8813 Patent”; as Senim‘ Uimeim‘
`
`
`
`
`for Manufacturing Stfiaiagy and? Innovation.
`
`
`
`
`
`.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Ihavaa Sin Physical Chginisn‘y ‘fi‘ojm Calaradfl State Uifiversity and a,P}1.E. in Chemical and
`
`
`
`
`
`
`
`
`
`
`
`BiQEngin‘earing fmm
`State University 131w; participatesd in. pflstdesimiai studies
`
`
`
`
`
`
`
`
`
`
`
`
`
`Biachemica] Engmeafing atitha Umfiiversity fif‘Vigginia. Ewing my smear, I have been. nammi as
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`an inventm‘ an cvea‘ US. patams am numeroug foreign patants directed ta the foimulatifin,
`
`
`
`
`
`Dr. Reddy’s - EX1007
`
`Page 1
`
`Dr. Reddy's - EX1007
`Page 1
`
`
`
`
`
`
`
`
`
`
`
`
`
`pmmssing andfar packaging (if pharmacautiaal 011a} disintegratin maximums ("tabla-ts
`
`
`
`
`
`
`swim)? 'I have. iiireet fixpéarience with film mmmemiai
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`sis-arms as wail as
`underflanfling 0f the unifm‘mity Gfflfm’fifiiit 0‘5 a‘3»1i‘“? 33353 “15111st f9?-
`
`
`
`testing the: same.
`
`
`
`
`
`
`
`1319663535113 “fphamaflgmim film
`
`
`
`
`
`film
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`.
`'Iihave read 1:11;; 'IGSIH Patent and the flffi Cis Acfian iSsuaéf {In Navemhef 295-2812 in the" Ffigxfimififlfifln
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`of the: ‘flfifi Pam: 'i’Office Action”) and the refemnees sited therein, and. 1 haw 3130' Kffi‘é’ifiwed- 1316
`
`
`
`
`
`
`
`
`
`
`
`
`to the indapemdem Glaims set-{faith in Patentee‘s Rspfiy t0 the (1*ffiieaActiaén
`
`
`
`enncmmndy fi!eé”hemwzith,.
`
`
`
`
`
`
`
`
`am‘andment
`
`
`
`II.
`
`
`
`
`
`
`
`
`
`
`
`Prnducin marking fitms in :acczm'dance with the "$33 Patent
`
` (cid:9)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Each 0;? the "’33 iats afresulting filing. (L015 1-?3}:wntaining appmximateiy 2,909,800 individuai
`
`
`
`
`
`
`
`
`
`
`
`
`ii} for Gamma-rem! use: and mgul‘atgry
`dosagg units par 10’: discussed harem weremafiufactm‘ad:
`
`
`
`
`
`
`
`
`
`
`
`
`
`appmvatg {iii} 'inwmpiianw with:
`Fwd and Drug Adminimatibn (“FDA”) standards: and
`
`
`
`
`
`
`
`
`
`
`
`
`
`regulatiansj inalufiing thcsereiming toanaiytigai Chemisait testing far variatian in anti’vav in. individua}
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`desage units; and {iii} in. acsemt'diame with they iinvaznt-imn dist: 1:03am}. in $164089 Patient, and as; claimad
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`the ‘0 89 Patent; bath. as .i'ssuad and as amended {in ‘thzePatflntefi-k Repiy if; 1125;: Offiw Astian; by:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`{a} farming axfiowabieipaléymer matrix camprismg a water-smiuble paiymer, a when: and a:
`
`
`
`
`
`
`
`
`matrix hwing asubmamiafléy unifiarm- digitributifln ofsaid. active;
`
`
`
`phmmacgeutiaal astive,
`
`
`
`
`
`
`
`
`
`
`(b1) Wasting: said leWabIe: pfiiymer matrix,
`
`
`
`
`
`
`
`
`viscfisity flan}. about
`"to abflut 108,900 cps;
`
`
`
`
`
`
`
`
`flo-wahie pa‘iymermanix haying a
`
`
`
`
`
`(a) amtmflizng,
`
`elasfic:
`
`
`
`
`
`
`
`
`
`
`thmugh a pram-:33. mmprising cutawayng saici pniymermatrix
`
`
`
`
`
`
`
`
`
`
`
`
`
`thmugh adrying appazmus and evapemting at least :a. partial“: of said 361th in farm 2; W330»
`
`
`
`
`
`
`
`
`
`
`having said active subsmntiailiy 1y disti‘ihuted fmughnusts within ,abaut the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`513i: 4 minutas hydrapicfly 'incrfiafsing the Vis‘fliflsity Gfsaifi paiymex matrix 11130161 initiation 9f
`
`
`
`
`
`
`
`
`
`
`
`
`
`drying. ta maintaifi saié substantially ‘unifm-‘m disstrihufizun of‘said .actizvefby baking—in or
`
`
`
`
`
`
`
`
`
`
`
`subsfamialiy pmveufing migrafimwf said acfive within said. viscxahsiagfizc film Whemin the
`
`
`
`
`
`
`
`
`.pelymer matrix temperature is: 108‘ 9EC 03F {353;
`
`
`
`
`
`
`
`
`
`Page 2
`
`Page 2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`visefireiastic filmlwhfirein said
`(:1) fomling the resulting. pharmaceutical fiim fmm
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`waiting ghamaaeezutica} film 3121.31.35: waiar saws-rat
`10% at less and said substantially unifcxrm
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`disffihutien 0f aative: by said laekingéin 0:17 substantially prewntingmigratian {if said. amine is
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`mainiainedfinsh that: unifemity fireman:- in' the amount affine Iactiva
`substantialiy equal
`
`
`
`
`
`
`
`
`
`
`
`sizecl individual dflssaga units, sampleii from different locations cf resuifing pharmafieufigal
`
`
`
`
`
`
`
`
`film, varies by {m mere,- than 19%.; and
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`{‘65) pfix'ifemling analytica} chemical taséts for wifiamaity ofccxntent of said aative Sin.
`
`
`
`
`
`
`
`
`
`
`
`substamially equal sized, individual dazaaga units of said. sampled faulting pharmaeaufical film,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`said tests, indiaafiiug that uniformity of Gamers? in tha amounmf the active: varies by m mare than
`
`
`
`
`
`
`
`
`
`
`
`
`[$63 Appenéix A} Said'IESLILfiHg phaflnaqemiaal film suitable foiz"cammemial and
`
`
`
`
`
`
`
`
`
`
`
`
`
`regulamry approval, Whgmin said raigmatoty appmval is pfavidefi by this
`Fund 3mg
`
`
`Administratian._
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Adfiitionalliys the uniformiiy 0f mutant. fits-31111911111: ofamive: as sampled fmm the 7‘3 101s of
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`making fiim. Writs 119 mm than 136% frsm'the desired amount, 0fthe active as indicated by
`
`
`
`
`
`
`
`
`
`
`said aflaiytiwl {331621131631 feasts fffim 4‘23} abuva. [See Appendix B]
`
` (cid:9)
`HI.
`
`
`
`
`
`
`
`
`
`
`Anal. 13921,]. asiin .,fmiflniiblfimiy,,Qf'CQntfimfifl’atsnteefs Resulting :; Filmg;
`
`
`
`6..
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`demonstrate the unifmmity of individual diisagfi unit fiims, I campijlcd individual dasagfit unit
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`data fm'f individual Lats Ii ’33: all Elf whiqh ware. éififiiasefl in .MQnflSfll‘s
`1:2 Aimuai
`
`
`
`
`
`Prcixduat Review to the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`7?. Ten (16) individuai dang units all having the :Same- dimemims were cut {but fi‘emdiffercm
`
`
`
`
`
`
`
`
`
`
`
`
`ififlafifilm Qf-wgh 9f the: 3’3 Eats af‘rasuiti-ng E11113 using a csaimnamia} Vpaakaging machine, thus
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`provifiing 173G Tandem}? sampled infiifiduat d‘asagevunits, fan each 13an the
`Separate .I'Gt‘s. All.
`
`
`
`
`
`
`
`
`
`
`
`
`sampiafi ware analyzed by 1%: Validated .Inefiiad, in mmpfianc‘e With FDA guidefinas and.
`
`
`
`
`
`
`
`
`
`
`
`regulatin Vx'ragarding samg:
`analyticai Chfimiflal misting; in which ‘tthhafiflacfiMticai activg
`
`
`
`
`
`Page 3
`
`Page 3
`
`
`
`
`
`
`
`I}.
`
`
`
`
`
`
`
`
`
`
`
`
`was extractad and: analyzfisd by High Perfommnce Liquid Chmmatagraghy (HFLC) againsi an
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`enema} standard tie; quantify the ammmt 01?“ active. prawn: in flash individual cimage unit.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Accerdinig m the invantive pmmss set {firth and claimed in the 1385:} Patent, and in amortiance
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`with FDA namemiatm‘eg I have prepmfed tables ShGWfl 2:5 Appexrxdifisas A, B and C, reflaefing the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`wife-unity Qif Wflfrfiflt 0f aetive of individual dusags units within particular Iota: and amass
`
`
`difiémm 11313.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`First, tilt}; unifm‘miiy {if 90111231101? activa in a {at is determian Ih‘mugh estflbiishing the; amount 0f
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`active {Aug}; actually presantrin Bafih sampied individual desagya unit fmim. thesame law) as
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`fictermincd. by taking the difim‘enee hatween the: amasth afaetive inthe' 3amp1awith the mag:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`aefive (Max-WW) minus the amaunt of actiwv in the sample with the least. amaum aflacféivue
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(#4311371134ng and dividing the: differenca by {he awxiaga amount if acme in the.”le samples (140th
`
`
`
`
`
`
`
`
`
`Sample Awerage). That. is: CMamem » Min-1mm) f ( {Amm Ami.“ + .Ammfifl The results
`
`
`
`
`
`
`
`in Appendix
`
`are
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Semnd, the unaiifmim £131 £3312” Czentent flGFQSS diffemnt 30:3 is'dateflninied fhi‘angfh estabfishihg the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`amaunt flf‘active actualiy prewar in emf: sampled individua} (image unit from a}; 73 1013 am:
`
`
`
`
`
`
`
`
`
`
`
`
`
`comparingthat amfiumtflf active with a"‘ta1:gsz’* 0r “zdes-irad“ 211110th (If active, camaineé therein.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`T1316: target 3111c;th 9f' v'c.1c:f£ibv£2a Wham iris a pharmaeeutiiaai, is areiérmd was
`“Label Claim“, ihus
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`identifing tin:- amcsunt ufpharmaesutiflal active in the film 1:0 amen; The: dasimd amaum
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`186% of the target; amaum; Each individual dasage unit film cut .f-mm any individual fat must
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`have the»; dgsimd 003$th 01“ phamaawtiaai active, varying
`miflrethat 119% fifemthe- t‘atgfi or
`
`
`
`
`
`dagir'ed amgunt; Sets: Appendix
`
`
`
`
`
`
`
`
`
` (cid:9)
`IV.
`
`
`
`
`
`
`
`@830 Patent i’mcasslmdmss.Fflms. Whit}:
`
`
`
`
`
`
`
`
`mired Unifmmift ofCantanf 0f
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Th€r~ res-111m Shawn in ‘tha appendices astahfifih that tin: regulfing: fiims produced by the inventive
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`metth {If' 31%: "03830 Patent-as tfiSClfi’sfiz} am} claian haw. the-‘imuired unifermity Of content based
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(in. anaiyfiflg? chemica} testing; Fitsg 1116 fimmmt cf azfi'v-te varies
`mi) mare {than
`
`
`
`
`
`
`
`
`
`
`
`
`daaagfi units. :sampikad fmma ‘partjiaular 1m ofrasuhifiggfilm
`Appanfiix
`
`
`
`
`betwam
`
`
`
`
`
`
`
`
`Page 4
`
`Page 4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`'S-ewniia.'an10unt of activa- amass difimznt his Bf wwlfingfilm variesna mare {ham {8% fmm
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`the desired zmfium 0“? 11m acfive,. See. Appendix 33. Finally, the uniformity 3f mn’tent of the 723
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`101$ Qf'regsulting film mflet‘s iWEfinanre‘Sifingfint standards; fm‘ exampia, the flaw shaws; (i) '46
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`lots Qflffisuifing film wherein maunifmmity (If cant-en: of active is Shawn with the amen-nit 0f
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`actim varying: by less than 5%;
`15 his aft-68111:“:ng film. wherein the unia‘brmity- 13f cement of
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`active is Shaw-n: with the amount efaetive varying 15:33,: Bess than, 4%; 4 1m of remitng film
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`whmein the unifcrmity ofmntrent afacfiva is. ShDWH with the amaunt cf acme: varying
`lass
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`than 3%.; and 1 East Gf'msuiting
`Whetidfl {h‘fit miibrmiiy thmnitant {If tactiv: is; 51mm with the
`
`
`
`
`
`
`
`
`
`anmuntof active varying; by only
`flee Appendix
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 harem? deciam margin statements made harem of my own hawkeng are true: and that
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`31} 81332611131113 made an infcxrmafifln and befietf are. ‘bsiieved ta: be true; and fizfihar that {base
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`staiements were made with thakmwlisdgfi that @1113)! féise: Statements and the 13m- s‘a maria are
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`punishabie by fihe or imprisanmem, or 50th, 'undmf Sgctieun 11301 ufT‘itla 1:8 0f the United Stags
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eadie, andf that such statements. may jéfiflpafd‘ififi the vafidfiity afthaappliwtifin arva 'pai‘gnts
`
`
`issued {harem}.
`
`
`
`
`
`
`
`
`
`
`
`Dated this 13th day oifMamh, X313
`
`
`
`
`
`
`
`x
`
`Arlie Bague
`
`
`
`
`
`
`
`
`
`Page 5
`
`Page 5
`
`
`
`
`
`
`
`
`
`{Max—Min)ILatSammieAverage
`
`
`
`
`
`4% v
`
`«9%
`
`8%
`
`6%
`
`2%% ~
`
`2%
`
`6%
`
`
`
`
`
`
`
`1
`
`4.
`
`“r- m 13
`
`
`“£6
`
`
`413 46 49'
`19 2,2 25 218
`
`
`
` (cid:9)
`
`Lot Mumbesr
`
`
`
`33
`
`as:
`
`
`
`
`
`1:3? 49'
`
`
`
`
`
`5:::§:‘:::;% Riga-laws???"39%; ‘
`
`
`
`.i'
`
`
`5 5:8
`
`
`
`
`:51
`
`
`
`8.4 a? m 713.
`
`
`
`
`
`
`Page 6
`
`Page 6
`
`
`
`
`
`
`
`
`
`1.01%.0 r
`
`
`
`‘1 6&0 '
`
`‘1 GM}
`
`33211
`
`1 man
`
`
`
`
`
` 1
`
`...intimdual'FilmDamageUnitAssay
`
`
`
` (“Aa?Target)
`
`.w'99:23
`
`w33"'0
`
`914%
`
`
`
`939- ~
`
`
`
`8&0
`
`33.0
`
`a
`
`
`v m 123:
`
`:16. 19. 22 25 2a 34' 34 ‘3? m is 46 49 52 55 53 64: 54. a? m 33
`
`Lat Number
`
`
`
`
`
`
`
`
`
`
`
`
`Page 7
`
`Page 7
`
`
`
`‘
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eats. $933.19 W53
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APPENDIX C.
`
`‘
`
`7
`
`
`‘
`
`
`
`
`
`V
`Lat-iesshan
`
`
` (cid:9)
`7% D'iiffesrenue
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 8
`
`Page 8
`
`(cid:9)
`(cid:9)
`
`
`
`
`
`
`CERTIFICATE OF FIRST CLASS SERVICE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`It is certified that a copy of this DECLARATION OF B. ARLIE BOGUE, PH.D.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNDER 37 C.F.R. § 1.132 has been served, by first class mail, on March 13, 2013, in its
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`entirety on the third party requester as provided in 37 CFR § 1.903 and 37 CFR § 1.248 at the
`
`
`
`
`addess below.
`
`
`
`
`
`
`DANIELLE L. HERRITT
`
`
`
`McCARTER & ENGLISH LLP
`
`
`
`265 FRANKLIN STREET
`
`
`BOSTON, MASSACHUSETTS 02110
`
`
`
`
`
`
`
`
`
`
`/Daniel A. Scola Jr./
`
`
`
`
`Daniel A. Scola, Jr.
`
`
`
`Registration No.: 29,855
`
`
`
`
`Attorney for the Patentee
`
`Page 9
`
`Page 9
`
`